Abhay Jajoo on CustomerInsights.AI, Agentic AI, and the Future of Life Sciences Commercial Analytics

Abhay Jajoo is helping life sciences companies use AI to find better answers faster. As CEO and Founder of CustomerInsights.AI, Abhay works with pharma, biotech, and life sciences teams to identify patients, understand physicians, improve commercial decision making, and make sales and marketing operations more efficient. CustomerInsights.AI recently won an AI Excellence Award for its work bringing hyper-vertical AI into life sciences commercial analytics.In this episode, Russ and Abhay explore why pharma commercial operations have been slow to move away from people-heavy consulting models, and why AI is now creating a better path for answering business questions at scale.They dive into CI Parthenon, CustomerInsights.AI’s foundational platform for integrating, transforming, modeling, and visualizing commercial data. Abhay explains how the platform reduces data movement, speeds up time to insight, and helps teams move from weeks of analysis to near real-time decision support.The conversation also covers CI Athena, the company’s agentic AI platform built specifically for life sciences commercial analytics. Abhay shares how Athena uses intelligent agents, workflows, and conversational interfaces to help users ask business questions, get grounded answers, and explore insights without needing to navigate siloed systems.Along the way, Abhay discusses pharma data complexity, patient and physician targeting, market access, contracting strategy, compliance, hallucination control, token management, enterprise AI adoption, and why the future of consulting may shift from people-heavy delivery to outcome-based technology models.Topics Covered:[00:01] Welcome and intro, Abhay Jajoo and CustomerInsights.AI’s AI Excellence Award win[00:29] What CustomerInsights.AI does for pharma and life sciences companies[01:03] Why Abhay saw a broken model in life sciences consulting[03:40] Better, faster, and more cost-effective commercial analytics[04:30] The silo problem across sales, marketing, and market access teams[05:23] Reducing time to insight from weeks to hours[07:17] Why life sciences AI is harder than generic GenAI[09:46] Business rules, therapeutic nuance, and explainable insights[11:25] What CI means and how Parthenon and Athena got their names[13:09] What enterprise clients need to see before trusting AI[15:39] How Athena uses agents, workflows, and conversational interfaces[17:56] What CustomerInsights.AI learned from Parthenon deployments[20:21] Security, compliance, guardrails, and token management[21:55] Deploying Athena inside the customer’s own environment[24:36] Infrastructure agnostic architecture and where CustomerInsights.AI’s IP sits[28:22] How pharma CIOs are responding to AI mandates[30:43] Why buying hyper-vertical AI can accelerate enterprise deployment[32:04] How AI may reshape life sciences consulting[35:56] Why CustomerInsights.AI is staying focused on life sciences commercial analytics[38:38] Final thoughts on AI, commercial analytics, and patient impact